耐用左心室辅助装置:对其优缺点的当代审查
Max Shin1, Nikhil Ganjoo1, Omar Toubat1
1Division of Cardiovascular Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Expert review of medical devices
|December 2, 2024
概括
左心室辅助器件 (LVAD) 为末期心力衰竭提供了心脏移植的重要替代方案. 持续的技术进步旨在改善结果并解决当前设备的局限性.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 医疗器械 医疗器械
背景情况:
- 心脏移植受限于供体的可用性和患者的病情.
- 左心室辅助器件 (LVAD) 对于稳定晚期心力衰竭患者至关重要.
- LVAD可以改善血液动力学和逆转末端器官损伤,允许患者出院.
研究的目的:
- 审查LVAD技术的发展情况.
- 讨论当前LVADs的好处,缺点和结果.
- 预览先进的心力衰竭管理的新兴技术.
主要方法:
- 审查历史和当前的LVAD技术.
- 工程进步和代改进的分析.
- 讨论当代结果和不良事件.
主要成果:
- 现代LVAD显著延长了终端心力衰竭患者的存活时间.
- 目前的设备提供了与心脏移植相比的生存潜力.
- 不良事件仍然是一个挑战,推动下一代设备的发展.
结论:
- LVAD在管理晚期心力衰竭方面发挥着关键作用.
- 新技术正在开发,以克服当前的局限性.
- 未来的LVAD有望在治疗心力衰竭方面提供更可持续的解决方案.
相关概念视频
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


